Details Basic Details Approval Date Thursday, July 13, 2017 Health Outcome(s) adverse pregnancy and fetal outcomes, lymphoma, malignancy Regulatory Link(s) (2) ARIA Memo FDA Approval Package Link(s) Sentinel Drug Study: Tremfya (Guselkumab) & Lymphoma